Nov 12 (Reuters) - AstraZeneca on Friday posted
$1.05 billion in COVID-19 vaccine sales for the third quarter
and the not-for-profit vaccine added one cent to profit in the
period, while the company reiterated its forecasts for 2021.
(Reporting by Pushkala Aripaka in Bengaluru and Ludwig Burger
in Frankfurt
Editing by Mark Potter)